SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Myron David Kor who wrote (2427)2/19/1998 8:26:00 PM
From: Bruce Rosen  Respond to of 7041
 
By the way, there have been two recent filings of institutional ownership of Zonagen, in addition to the American Funds group. Franklin owns about 800,000 shares, a seven percent stake. T. Rowe Price owns more than 1,000,000 shares of Zonagen, over a nine percent stake.

You can find these filings on Edgar.



To: Myron David Kor who wrote (2427)2/20/1998 10:11:00 AM
From: Diamondcutter  Read Replies (1) | Respond to of 7041
 
The Wessels, Arnold & Henderson analyst is Stephanie Feldman (612) 373-6248. sfeldman@wessels.com